TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15231974

Group type: EXPERIMENTAL
Intervention: Early-treatment group (M&T performed promptly)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Late-treatment group (M&T performed after a defined extended period)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Nontrial group (no M&T)
Number of subjects: 429
Study: 11409520

Group type: EXPERIMENTAL
Intervention: 5000 U of heparin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 9408302

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 42
Study: 8591483

Group type: EXPERIMENTAL
Intervention: Computerized phone follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improved access to medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One-on-one follow-up conversations concerning compliance issues
Number of subjects: 0
Study: 2475710

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5, 5, and 7.5 mg b.i.d. every 3rd week)
Number of subjects: 20
Study: 1021720

Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 40
Study: 31148210

Group type: EXPERIMENTAL
Intervention: Enteral dextrose infusion for 24 hours (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Water (placebo) infusion for 24 hours (n=30)
Number of subjects: 60
Study: 31062050

Group type: EXPERIMENTAL
Intervention: Mechanical power normalized to predicted body weight (norMP)
Number of subjects: 5159

Group type: COMPARATOR
Intervention: Absolute mechanical power (MP)
Number of subjects: 5159

Group type: COMPARATOR
Intervention: Gradient boosting machine
Number of subjects: 5159

Group type: EXPERIMENTAL
Intervention: norMP in patients with mild ARDS
Number of subjects: 5159
Study: 27818304

Group type: EXPERIMENTAL
Intervention: mHealth-program, TXT2BFiT (three-month intensive phase and six-month maintenance phase)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: mHealth-program, TXT2BFiT
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 250
Study: 25906706

Group type: EXPERIMENTAL
Intervention: NCH gel
Number of subjects: 216

Group type: COMPARATOR
Intervention: saline
Number of subjects: 216
Study: 24742116

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Group multimodal intervention (MMI)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 164
Study: 22948406

Group type: EXPERIMENTAL
Intervention: TeleFamilies intervention with advanced practice nurse as care coordinator; details on dosage and duration not specified.
Number of subjects: 0
Study: 20186843

Group type: EXPERIMENTAL
Intervention: Low levels of plasma IP-10
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Low levels of intrahepatic IP-10
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Low plasma levels of IP-10
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Pretreatment plasma samples from NORDynamIC trial
Number of subjects: 265
Study: 18268075

Group type: COMPARATOR
Intervention: Ramipril (15 mg/day)
Number of subjects: 5269

Group type: COMPARATOR
Intervention: Rosiglitazone (8 mg/day)
Number of subjects: 5269

Group type: EXPERIMENTAL
Intervention: Placebo (for both interventions)
Number of subjects: 5269
Study: 16200556

Group type: EXPERIMENTAL
Intervention: Home chemotherapy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hospital chemotherapy
Number of subjects: 23
Study: 15785179

Group type: EXPERIMENTAL
Intervention: Endovascular therapies (angioplasty, stenting, endoluminal stent grafts)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stent-supported carotid angioplasty with cerebral protection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less invasive techniques for abdominal aortic aneurysms using endoluminal stent grafts
Number of subjects: 0
Study: 10743395

Group type: EXPERIMENTAL
Intervention: Teaching strategy by a public health nurse with leaflet and video
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Teaching strategy by a breast cancer survivor with slides and silicon breast models
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control strategy by a primary care nurse with leaflet and video based on Health Secretariat's guidelines
Number of subjects: 149
Study: 9685782

Group type: EXPERIMENTAL
Intervention: Scanning laser ophthalmoscopy in children with glaucoma and myopia (group I)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 29
Study: 8497821

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate with a 750 ml spacer (group S)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate without a spacer (group MDI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups at 2 mg/day of beclomethasone dipropionate
Number of subjects: 50
Study: 3305379

Group type: EXPERIMENTAL
Intervention: Hexapneumine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clistine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hexapneumine and Clistine
Number of subjects: 100
Study: 29147731

Group type: EXPERIMENTAL
Intervention: Hypokinesia (60 min of wearing a stiff neck collar)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypokinesia (120 min of wearing a stiff neck collar)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cervical hyperkinesia (20 min of extensive active neck movement)
Number of subjects: 20
Study: 28318164

Group type: EXPERIMENTAL
Intervention: Gastric tube interposition by touching laryngeal prominence
Number of subjects: 66

Group type: COMPARATOR
Intervention: Regular gastric tube interposition
Number of subjects: 66
Study: 25047825

Group type: EXPERIMENTAL
Intervention: Dialysate sodium 135 mM
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dialysate sodium 140 mM
Number of subjects: 96
Study: 22537558

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (ESCAPE: Evaluation of Stepped Care for Chronic Pain)
Number of subjects: 26
Study: 20810877

Group type: EXPERIMENTAL
Intervention: Aphasia treatment targeting anomia (30 hours of treatment)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Aphasia treatment targeting anomia
Number of subjects: 26
Study: 18438689

Group type: EXPERIMENTAL
Intervention: Topical morphine (0.1%, 0.2%, 0.4%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Topical buprenorphine (0.01%, 0.02%, 0.1%)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 16
Study: 15958804

Group type: EXPERIMENTAL
Intervention: Bortezomib (1.3 mg/m² IV on days 1, 4, 8, and 11 for eight three-week cycles, then days 1, 8, 15, and 22 for three five-week cycles)
Number of subjects: 669

Group type: COMPARATOR
Intervention: High-dose dexamethasone (40 mg orally on days 1-4, 9-12, and 17-20 for four five-week cycles, then days 1-4 for five four-week cycles)
Number of subjects: 669
Study: 12724125

Group type: EXPERIMENTAL
Intervention: Mandibular advancement splint (MAS)
Number of subjects: 10
Study: 10643226

Group type: EXPERIMENTAL
Intervention: Combination treatment with insulin and metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 0
Study: 8896734

Group type: EXPERIMENTAL
Intervention: Cyclosporine and steroid immunosuppressive therapy (CSA regimen)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine (4 mg/kg/day), steroid therapy, and 21-day course of 500 mg/day antilymphocyte globulin (ALG 1 regimen)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine (6 mg/kg/day), steroid therapy, and 14-day course of 1,000 mg/day antilymphocyte globulin (ALG 2 regimen)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine (6 mg/kg/day), steroid therapy, and 14-day course of 1,000 mg/day antilymphocyte globulin followed by 2 mg/kg/day mizoribine (ALG 3 regimen)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: FK506 and steroid therapy (FK506 regimen)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Cyclosporine and steroid therapy
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: ALG 1 regimen
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: ALG 2 regimen
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: ALG 3 regimen
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: FK506 regimen
Number of subjects: 276
Study: 8287666

Group type: EXPERIMENTAL
Intervention: Haemodialysis
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Chronic renal failure (not receiving maintenance dialysis)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control subjects (healthy)
Number of subjects: 35
Study: 3477989

Group type: EXPERIMENTAL
Intervention: Abdominal hysterectomy
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Supravaginal uterine amputation
Number of subjects: 212

Group type: COMPARATOR
Intervention: Comparison at 3 years
Number of subjects: 212
Study: 29125975

Group type: EXPERIMENTAL
Intervention: Parental monitoring
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Positive family relations
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Prosocial peer affiliation
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Deviant peer affiliation
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Friendship environment
Number of subjects: 999
Study: 27523980

Group type: EXPERIMENTAL
Intervention: Targeted biopsies (biopsies collected from locations of suspected neoplasia), n = 124
Number of subjects: 246

Group type: COMPARATOR
Intervention: Random biopsies (4 random biopsies collected every 10 cm in addition to targeted biopsies), n = 122
Number of subjects: 246
Study: 24553695

Group type: EXPERIMENTAL
Intervention: Echium oil (EO) 17 g/d (2 g SDA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fish oil (FO) 17 g/d (1.9 g EPA)
Number of subjects: 80
Study: 23249501

Group type: EXPERIMENTAL
Intervention: Adjunctive rifampicin (600-900 mg/day; orally or intravenously)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940
Study: 20456738

Group type: COMPARATOR
Intervention: Levofloxacin 500 mg daily
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily
Number of subjects: 65
Study: 18215589

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DESs)
Number of subjects: 2000
Study: 16199841

Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy (40 sessions)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Community-delivered psychodynamic therapy
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 156
Study: 14520722

Group type: EXPERIMENTAL
Intervention: 25‐OH‐vitamin D (cholecalciferol) 15 microg (600 IU) once daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 11220352

Group type: EXPERIMENTAL
Intervention: Acarbose (half a pill before lunch and half a pill before dinner)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (50 mg of starch)
Number of subjects: 30
Study: 8889120

Group type: EXPERIMENTAL
Intervention: Verbal encouragement
Number of subjects: 20

Group type: COMPARATOR
Intervention: No verbal encouragement (Control)
Number of subjects: 20
Study: 1856305

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel 2%
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amine fluoride gel 1.25%
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stannous fluoride gel 4%
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10
Study: 7174305

Group type: EXPERIMENTAL
Intervention: Pizotifen 0.5 mg t.d.s.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pizotifen 1.5 mg nocte
Number of subjects: 17
Study: 31214178

Group type: EXPERIMENTAL
Intervention: Tadalafil and MUC1/polyICLC vaccine
Number of subjects: 0
Study: 28174906

Group type: EXPERIMENTAL
Intervention: 30 mg/kg praziquantel
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 40 mg/kg praziquantel
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 50 mg/kg praziquantel
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 3 × 25 mg/kg praziquantel
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 26864131

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg once daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 25077910

Group type: EXPERIMENTAL
Intervention: Transforaminal thoracic interbody fusion (TTIF)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Posteroanterior (P-A) fusion
Number of subjects: 61
Study: 22391540

Group type: EXPERIMENTAL
Intervention: Bedaquiline (TMC207)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 19619101

Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention for general practitioners
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (standard practice)
Number of subjects: 107
Study: 17617892

Group type: EXPERIMENTAL
Intervention: Immediate delivery after PPROM
Number of subjects: 520

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 520
Study: 15116254

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin (LMWH) thromboprophylaxis
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (healthy pregnant women without antithrombotics)
Number of subjects: 61
Study: 11668032

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.25, 0.75, or 1.5 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bethanechol (2.5, 5, or 10 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study: 9690105

Group type: EXPERIMENTAL
Intervention: Self-efficacy in discussing mammography with health providers
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Social influence from network members regarding mammograms
Number of subjects: 194
Study: 7977327

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conversion from CsA to azathioprine
Number of subjects: 20
Study: 2686610

Group type: EXPERIMENTAL
Intervention: ceftazidime (+/‐ flucloxacillin) (n = 52)
Number of subjects: 102

Group type: COMPARATOR
Intervention: azlocillin plus amikacin (+/‐ flucloxacillin) (A&A, n = 50)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: ceftazidime (+/‐ flucloxacillin)
Number of subjects: 102

Group type: COMPARATOR
Intervention: azlocillin plus amikacin (+/‐ flucloxacillin)
Number of subjects: 102
Study: 818818

Group type: EXPERIMENTAL
Intervention: Glibenclamide (GCL)
Number of subjects: 50
Study: 29668561

Group type: EXPERIMENTAL
Intervention: Nitazoxanide plus lactulose
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lactulose and placebo
Number of subjects: 120
Study: 28763881

Group type: EXPERIMENTAL
Intervention: Memantine combined Reinhartdt And Sea Cucumber Capsule (R.S.C)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Single Memantine
Number of subjects: 158
Study: 25619686

Group type: EXPERIMENTAL
Intervention: Aloe cream
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Powder
Number of subjects: 248
Study: 23771550

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 21644312

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with general anesthesia (ACGA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 39
Study: 18840368

Group type: EXPERIMENTAL
Intervention: Midodrine (5 mg, oral)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 17065942

Group type: EXPERIMENTAL
Intervention: Children with HCP
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control children
Number of subjects: 42
Study: 12580653

Group type: EXPERIMENTAL
Intervention: 3 g of HMB per day for 4 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 10831205

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (1.0 mg for age > 60 yr; 1.5 mg for age ≤ 59 yr)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (standardized anesthetic with fentanyl, propofol, and pancuronium)
Number of subjects: 25
Study: 9106275

Group type: EXPERIMENTAL
Intervention: Original and reversed (mirror-image) viewing conditions in Experiment 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Original and reversed (mirror-image) viewing conditions in Experiment 2
Number of subjects: 0
Study: 8476829

Group type: EXPERIMENTAL
Intervention: Endometrial resection
Number of subjects: 200

Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 200
Study: 2428219

Group type: EXPERIMENTAL
Intervention: Tiacrilast (Ro 22-3747) 350 mg oral dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cromoglycate 20 mg by inhalation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29608460

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Parental Training (PT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Parental Training/Methylphenidate (PT/MPH)
Number of subjects: 28
Study: 27861516

Group type: EXPERIMENTAL
Intervention: mCME intervention - Group 2 (passive model): daily SMS bullet point, required to reply to acknowledge receipt
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: mCME intervention - Group 3 (interactive model): SMS in multiple choice question format with immediate feedback
Number of subjects: 638

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: mCME intervention (both Groups 2 and 3)
Number of subjects: 638
Study: 24508367

Group type: EXPERIMENTAL
Intervention: short-term psychotherapy (short-term psychodynamic or solution-focused)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: long-term psychodynamic psychotherapy
Number of subjects: 326

Group type: COMPARATOR
Intervention: low level of social support
Number of subjects: 326
Study: 22642356

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal to down‐regulate responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different reappraisal task
Number of subjects: 0
Study: 19810668

Group type: EXPERIMENTAL
Intervention: Simulated clinical experiences
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional clinical experiences
Number of subjects: 74
Study: 18591525

Group type: EXPERIMENTAL
Intervention: Sucrose (2 mL of a 24% sucrose solution)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 15741556

Group type: EXPERIMENTAL
Intervention: ARILVAX
Number of subjects: 1107

Group type: COMPARATOR
Intervention: YF-VAX
Number of subjects: 1107
Study: 12939564

Group type: EXPERIMENTAL
Intervention: lercanidipine 10 mg
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: felodipine 10 mg
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: nifedipine gastrointestinal therapeutic system 30 mg
Number of subjects: 250

Group type: COMPARATOR
Intervention: All groups (lercanidipine, felodipine, nifedipine)
Number of subjects: 250
Study: 10788737

Group type: EXPERIMENTAL
Intervention: 12-week health promotion intervention
Number of subjects: 35
Study: 8869092

Group type: EXPERIMENTAL
Intervention: Cisplatin 6 mg/m2 administered 1-2 hours before each radiation fraction, with escalating total doses during treatment.
Number of subjects: 38
Study: 1531095

Group type: EXPERIMENTAL
Intervention: T10B9.1A‐31
Number of subjects: 38

Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 38
Study: 6238116

Group type: EXPERIMENTAL
Intervention: ICI 118630 (Zoladex) 3.6 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ICI 118630 (Zoladex) 1.8 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ICI 118630 (Zoladex) 0.9 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ICI 118630 (Zoladex) (all doses)
Number of subjects: 22
Study: 30860000

Group type: EXPERIMENTAL
Intervention: Amphetamine extended-release oral suspension (AMPH EROS)
Number of subjects: 0
Study: 28778126

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Social Support
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Feeling rested upon waking
Number of subjects: 307
Study: 27734492

Group type: EXPERIMENTAL
Intervention: Sciatic nerve catheter between the tibial and peroneal components
Number of subjects: 84

Group type: COMPARATOR
Intervention: Tibial nerve catheter medial to the tibial nerve
Number of subjects: 84
Study: 25339485

Group type: EXPERIMENTAL
Intervention: Spironolactone (20 mg/d) treatment group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional treatment group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (sinus rhythm)
Number of subjects: 67
Study: 22866821

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole (A + D)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Aspirin only (A)
Number of subjects: 662
Study: 19931382

Group type: EXPERIMENTAL
Intervention: 2+1-dose schedule
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 3+1-dose schedule
Number of subjects: 2
Study: 17509485

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 1018

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1018
Study: 15705360

Group type: EXPERIMENTAL
Intervention: Riluzole (50-200 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lithium (open treatment for a minimum of 4 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 14
Study: 11917239

Group type: EXPERIMENTAL
Intervention: Cyclosporin-A (CsA) 2 mg/kg twice daily for 12 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9457004

Group type: EXPERIMENTAL
Intervention: Self-administered physical activity frequency questionnaire (PAFQ)
Number of subjects: 919

Group type: COMPARATOR
Intervention: Heart rate monitor
Number of subjects: 919
Study: 7606604

Group type: EXPERIMENTAL
Intervention: Paraffin-coated human cerumen plug placed in one ear
Number of subjects: 43